IL104600A0 - Arylalkoxyphenoxy-imidazoline compounds and pharmaceutical compositions containing them - Google Patents
Arylalkoxyphenoxy-imidazoline compounds and pharmaceutical compositions containing themInfo
- Publication number
- IL104600A0 IL104600A0 IL104600A IL10460093A IL104600A0 IL 104600 A0 IL104600 A0 IL 104600A0 IL 104600 A IL104600 A IL 104600A IL 10460093 A IL10460093 A IL 10460093A IL 104600 A0 IL104600 A0 IL 104600A0
- Authority
- IL
- Israel
- Prior art keywords
- arylalkoxyphenoxy
- pharmaceutical compositions
- compositions containing
- imidazoline compounds
- imidazoline
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D233/22—Radicals substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epoxy Resins (AREA)
- Reinforced Plastic Materials (AREA)
- Plural Heterocyclic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/832,556 US5216008A (en) | 1992-02-06 | 1992-02-06 | Arylalkoxyphenoxy-imidazoline compounds |
| US99017492A | 1992-12-24 | 1992-12-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL104600A0 true IL104600A0 (en) | 1993-06-10 |
Family
ID=27125545
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL104600A IL104600A0 (en) | 1992-02-06 | 1993-02-03 | Arylalkoxyphenoxy-imidazoline compounds and pharmaceutical compositions containing them |
| IL12253797A IL122537A0 (en) | 1992-02-06 | 1997-12-10 | Arylalkoxyphenoxy-imidazoline compounds process for their preparation and pharmaceutical compositions containing them |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL12253797A IL122537A0 (en) | 1992-02-06 | 1997-12-10 | Arylalkoxyphenoxy-imidazoline compounds process for their preparation and pharmaceutical compositions containing them |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US5407954A (zh) |
| EP (1) | EP0625969B1 (zh) |
| JP (1) | JPH07504167A (zh) |
| KR (1) | KR100276994B1 (zh) |
| AT (1) | ATE199547T1 (zh) |
| CA (1) | CA2129142A1 (zh) |
| DE (1) | DE69329994T2 (zh) |
| DK (1) | DK0625969T3 (zh) |
| ES (1) | ES2156868T3 (zh) |
| FI (1) | FI943637A0 (zh) |
| GR (1) | GR3035915T3 (zh) |
| HU (1) | HUT67527A (zh) |
| IL (2) | IL104600A0 (zh) |
| MX (1) | MX9300601A (zh) |
| NO (1) | NO304597B1 (zh) |
| NZ (1) | NZ246823A (zh) |
| PT (1) | PT625969E (zh) |
| TW (1) | TW366338B (zh) |
| WO (1) | WO1993016051A1 (zh) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0408470A1 (en) * | 1989-07-06 | 1991-01-16 | Eastman Kodak Company | Maleated polypropylene blends for melt-bonding applications |
| CA3025884C (en) | 2016-06-24 | 2023-03-07 | Ohio University | Glucose transport inhibitors and methods of using same |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1695555A1 (de) * | 1967-02-23 | 1970-07-16 | Nordmark Werke Gmbh | Neue Aryloxy-isoalkyl-delta2-imidazoline und deren Saeureadditionssalze sowie Verfahren zu ihrer Herstellung |
| CA2027530C (en) * | 1989-10-20 | 2001-05-08 | Jules Freedman | W-phenoxy-heterocyclic compounds |
-
1993
- 1993-01-12 ES ES93903073T patent/ES2156868T3/es not_active Expired - Lifetime
- 1993-01-12 KR KR1019940702686A patent/KR100276994B1/ko not_active IP Right Cessation
- 1993-01-12 HU HU9402283A patent/HUT67527A/hu unknown
- 1993-01-12 PT PT93903073T patent/PT625969E/pt unknown
- 1993-01-12 AT AT93903073T patent/ATE199547T1/de not_active IP Right Cessation
- 1993-01-12 DK DK93903073T patent/DK0625969T3/da active
- 1993-01-12 CA CA002129142A patent/CA2129142A1/en not_active Abandoned
- 1993-01-12 EP EP93903073A patent/EP0625969B1/en not_active Expired - Lifetime
- 1993-01-12 JP JP5514064A patent/JPH07504167A/ja not_active Ceased
- 1993-01-12 DE DE69329994T patent/DE69329994T2/de not_active Expired - Fee Related
- 1993-01-12 WO PCT/US1993/000238 patent/WO1993016051A1/en active IP Right Grant
- 1993-01-12 NZ NZ246823A patent/NZ246823A/en unknown
- 1993-02-03 TW TW082100712A patent/TW366338B/zh active
- 1993-02-03 IL IL104600A patent/IL104600A0/xx unknown
- 1993-02-04 MX MX9300601A patent/MX9300601A/es not_active IP Right Cessation
-
1994
- 1994-02-09 US US08/194,137 patent/US5407954A/en not_active Expired - Fee Related
- 1994-08-05 NO NO942917A patent/NO304597B1/no unknown
- 1994-08-05 FI FI943637A patent/FI943637A0/fi not_active Application Discontinuation
-
1997
- 1997-12-10 IL IL12253797A patent/IL122537A0/xx unknown
-
2001
- 2001-05-22 GR GR20010400769T patent/GR3035915T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1993016051A1 (en) | 1993-08-19 |
| HU9402283D0 (en) | 1994-10-28 |
| MX9300601A (es) | 1993-08-01 |
| EP0625969B1 (en) | 2001-03-07 |
| IL122537A0 (en) | 1998-06-15 |
| NZ246823A (en) | 1996-06-25 |
| PT625969E (pt) | 2001-08-30 |
| AU671270B2 (en) | 1996-08-22 |
| TW366338B (en) | 1999-08-11 |
| US5407954A (en) | 1995-04-18 |
| GR3035915T3 (en) | 2001-08-31 |
| NO942917L (no) | 1994-08-05 |
| KR100276994B1 (ko) | 2002-06-20 |
| CA2129142A1 (en) | 1993-08-19 |
| DK0625969T3 (da) | 2001-04-30 |
| HUT67527A (en) | 1995-04-28 |
| FI943637A (fi) | 1994-08-05 |
| DE69329994T2 (de) | 2001-06-28 |
| NO942917D0 (zh) | 1994-08-05 |
| DE69329994D1 (en) | 2001-04-12 |
| JPH07504167A (ja) | 1995-05-11 |
| FI943637A0 (fi) | 1994-08-05 |
| NO304597B1 (no) | 1999-01-18 |
| ES2156868T3 (es) | 2001-08-01 |
| AU3442293A (en) | 1993-09-03 |
| EP0625969A1 (en) | 1994-11-30 |
| KR950700260A (ko) | 1995-01-16 |
| ATE199547T1 (de) | 2001-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS4695A (is) | (Metýlsúlfónýl)fenýl-2-(5H)-fúranón sem sýklóoxýgenasa-2 tálmar | |
| AP9600804A0 (en) | Therapeutic amides. | |
| NZ514711A (en) | Compounds useful as anti-inflammatory agents | |
| NZ331941A (en) | Pentafluorobenzenesulfonamides and analogs and use in regulation of LDL receptor synthesis | |
| MY115339A (en) | Compositions containing micronized nebivolol | |
| BG103399A (en) | New heterocycle-substituted benzamides and their application for the treatment of diseases | |
| EP0793489A4 (en) | AGENTS FOR TREATING SKIN DISEASES | |
| PL309282A1 (en) | Application of 2-amino-6-n-propyl-amino- 4,5,6,7-tetrahydrobenzothiasole (pramipexol) as an antidepressant | |
| ZA986673B (en) | Use of a combination of an inhibitor of converting enzyme and a diuretic for treating microcirculatory disorders | |
| MX9602861A (es) | Mezcla estabilizante sinergistica. | |
| MD502G2 (ro) | Derivaţi noi ai adenozinei, procedee de preparare a lor, compoziţii farmaceutice ce le conţin | |
| MX9801190A (es) | Inhibidores de prolil endopeptidasa. | |
| BG103632A (en) | Pharmaceutical compositions containing ibuprophene and domperidon for migraine treatment | |
| IL126199A0 (en) | Nasal pharmaceutical composition for the treatment of delayed emesis | |
| IL104600A0 (en) | Arylalkoxyphenoxy-imidazoline compounds and pharmaceutical compositions containing them | |
| AU4706293A (en) | Therapeutic use of phosphoryl-l-serine-n-acyl-sphingosine | |
| HUT73231A (en) | Pharmaceutical compositions with 17-beta-monosubstituted-carbamoyl-4-aza-5-alpha-androst-1-en-3-ones for treatment of chronic prostatitis | |
| ATE158301T1 (de) | 4-aza-pregnan-5-alpha-reductase isozym 1 inhibitoren | |
| HUT71512A (en) | N-(3-chlorophenyl)-piperazine derivatives for producing alkyl-trazodon derivatives and process for producing them | |
| MXPA98005355A (es) | Derivados de 5-[(heteroaril) alquil]-3 -oxo-pirido [1, 2-a]bencimidazol -4-carboxamida utiles en el tratamiento de trastornos del sistema nervioso central. | |
| ZA939199B (en) | Methylbutoxy-propionitriles | |
| ES2027507A6 (es) | Procedimiento de preparacion de derivados selenofenicos. | |
| GEP20053513B (en) | 2-Aminocarbonyl-9H-Purine Derivatives | |
| MX9603797A (es) | Agentes terapeuticos para su uso en la terapia del cancer. | |
| MX9700125A (es) | Compuestos de pirimidina. |